Cargando…

Design, Synthesis, and Validation of a Novel [(11)C]Promethazine PET Probe for Imaging Abeta Using Autoradiography

Promethazine, an antihistamine drug used in the clinical treatment of nausea, has been demonstrated the ability to bind Abeta in a transgenic mouse model of Alzheimer’s disease. However, so far, all of the studies were performed in vitro using extracted tissues. In this work, we report the design an...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitmore, Clayton A., Boules, Mariam I., Behof, William J., Haynes, Justin R., Koktysh, Dmitry, Rosenberg, Adam J., Tantawy, Mohammed N., Pham, Wellington
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070574/
https://www.ncbi.nlm.nih.gov/pubmed/33920113
http://dx.doi.org/10.3390/molecules26082182
Descripción
Sumario:Promethazine, an antihistamine drug used in the clinical treatment of nausea, has been demonstrated the ability to bind Abeta in a transgenic mouse model of Alzheimer’s disease. However, so far, all of the studies were performed in vitro using extracted tissues. In this work, we report the design and synthesis of a novel [(11)C]promethazine PET radioligand for future in vivo studies. The [(11)C]promethazine was isolated by RP-HPLC with radiochemical purity >95% and molar activity of 48 TBq/mmol. The specificity of the probe was demonstrated using human hippocampal tissues via autoradiography.